During cell injury in the absence of infectious threats, such as ischemia, radiation, trauma, and autoimmune disease, HMGB1 is released as an early mediator that balances the release of several cytokines, such as TNF, and tissue damage via molecular mechanisms involving signalling via binding of HMGB1 and TLR4 [15]. Here, TLR4 is linked to autoimmune disease.